Sharlene M. Day

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary

Steve R. Ommen, Seema Mital, Michael A. Burke et al. · Journal of the American College of Cardiology · 2020 · 983 citations

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +8

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy

Carolyn Y. Ho, Sharlene M. Day, Euan A. Ashley et al. · Circulation · 2018 · 776 citations · Full text

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Steve R. Ommen, Seema Mital, Michael A. Burke et al. · Journal of the American College of Cardiology · 2020 · 651 citations

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +6

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Steve R. Ommen, Carolyn Y. Ho, Irfan M. Asif et al. · Circulation · 2024 · 494 citations

Dystrophic heart failure blocked by membrane sealant poloxamer

Soichiro Yasuda, DeWayne Townsend, Daniel E. Michele et al. · Nature · 2005 · 314 citations · Full text

Heart Failure, Structural Heart Disease, Physiology +3